BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 9372172)

  • 1. Remodeling of junctional complexes during the development of the outer blood-retinal barrier.
    Williams CD; Rizzolo LJ
    Anat Rec; 1997 Nov; 249(3):380-8. PubMed ID: 9372172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the blood-retinal barrier in vitro: formation of tight junctions as revealed by occludin and ZO-1 correlates with the barrier function of chick retinal pigment epithelial cells.
    Konari K; Sawada N; Zhong Y; Isomura H; Nakagawa T; Mori M
    Exp Eye Res; 1995 Jul; 61(1):99-108. PubMed ID: 7556475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A culture model of development reveals multiple properties of RPE tight junctions.
    Ban Y; Rizzolo LJ
    Mol Vis; 1997 Dec; 3():18. PubMed ID: 9479009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apical and basal regulation of the permeability of the retinal pigment epithelium.
    Peng S; Rahner C; Rizzolo LJ
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):808-17. PubMed ID: 12556417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocalization of tight junction proteins, occludin and ZO-1, and glucose transporter GLUT1 in cells of the blood-ocular barrier in the mouse eye.
    Tserentsoodol N; Shin BC; Suzuki T; Takata K
    Histochem Cell Biol; 1998 Dec; 110(6):543-51. PubMed ID: 9860252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spatial organization of apical junctional complex-associated proteins in feline and human corneal endothelium.
    Petroll WM; Hsu JK; Bean J; Cavanagh HD; Jester JV
    Curr Eye Res; 1999 Jan; 18(1):10-9. PubMed ID: 10075198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial characterization of the human retinal endothelial cell tight and adherens junction complexes.
    Russ PK; Davidson MK; Hoffman LH; Haselton FR
    Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2479-85. PubMed ID: 9804158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption.
    Musch MW; Walsh-Reitz MM; Chang EB
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G222-31. PubMed ID: 16239402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of JAM-A, AF-6, PAR-3 and PAR-6 during the assembly and remodeling of RPE tight junctions.
    Luo Y; Fukuhara M; Weitzman M; Rizzolo LJ
    Brain Res; 2006 Sep; 1110(1):55-63. PubMed ID: 16859655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function.
    Mandell KJ; Berglin L; Severson EA; Edelhauser HF; Parkos CA
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3928-36. PubMed ID: 17724169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal pigment epithelial cells from dystrophic rats form normal tight junctions in vitro.
    Chang CW; Defoe DM; Caldwell RB
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):188-95. PubMed ID: 9008643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin.
    Youakim A; Ahdieh M
    Am J Physiol; 1999 May; 276(5):G1279-88. PubMed ID: 10330020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes.
    Pummi K; Malminen M; Aho H; Karvonen SL; Peltonen J; Peltonen S
    J Invest Dermatol; 2001 Nov; 117(5):1050-8. PubMed ID: 11710912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogold study of interendothelial junction-associated and glucose transporter proteins during postnatal maturation of the mouse blood-brain barrier.
    Vorbrodt AW; Dobrogowska DH; Tarnawski M
    J Neurocytol; 2001 Aug; 30(8):705-16. PubMed ID: 12118158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells.
    Bailey TA; Kanuga N; Romero IA; Greenwood J; Luthert PJ; Cheetham ME
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):675-84. PubMed ID: 14744914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic strain-mediated regulation of vascular endothelial occludin and ZO-1: influence on intercellular tight junction assembly and function.
    Collins NT; Cummins PM; Colgan OC; Ferguson G; Birney YA; Murphy RP; Meade G; Cahill PA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):62-8. PubMed ID: 16269664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression.
    Guillemot L; Hammar E; Kaister C; Ritz J; Caille D; Jond L; Bauer C; Meda P; Citi S
    J Cell Sci; 2004 Oct; 117(Pt 22):5245-56. PubMed ID: 15454572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polarity and the development of the outer blood-retinal barrier.
    Rizzolo LJ
    Histol Histopathol; 1997 Oct; 12(4):1057-67. PubMed ID: 9302567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal epithelial tight junctions and their response to lipopolysaccharide challenge.
    Yi X; Wang Y; Yu FS
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4093-100. PubMed ID: 11095601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells.
    Villarroel M; García-Ramírez M; Corraliza L; Hernández C; Simó R
    Exp Eye Res; 2009 Dec; 89(6):913-20. PubMed ID: 19660451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.